Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Novasep Expands and Opens Subsidiary in India

Published: Monday, December 16, 2013
Last Updated: Monday, December 16, 2013
Bookmark and Share
Novasep Process Engineering Services PVT LTD will meet India’s increasing need for high efficacy processes for its fast growing food and feed industries.

Novasep has announced that it is expanding its presence in India with the opening of Novasep Process Engineering Services PCT LTD, a part of its Industrial Biotech Business Unit.

The new office will enable Novasep to serve more closely industries in India producing functional and commodity food and feed ingredients, milk derivatives and bio-based chemicals.

Michel Cotillon, a Novasep veteran, formerly R&D Head of the Industrial Biotech business and then its Area Sales Manager for France and Benelux, has been promoted to head the subsidiary as General Manager.

Novasep’s expansion to Bangalore, India, comes at a time when India’s food and feed ingredients industries are experiencing fast growth. It follows Novasep’s successful expansion of its team in China in 2012.

“Novasep’s set up in India is another key milestone in our strategy to expand our geographical presence,” said Michel Spagnol, CEO at Novasep. “After our success in China, Novasep India is well placed to support our growth in future years.”

Novasep’s Indian subsidiary will provide expert local support to sugar mill operators in India to integrate Novasep’s optimized processes. These processes enhance the quality of fine liquors, increase sugar production yields or competitively produce liquid sugar with Applexion™ ion exchange, a technology pioneered by Novasep and largely used in the food industry.

For the Indian dairy industry, Novasep will provide local expertise in developing cost-effective processes that guarantee the performance of:
• Whey demineralization using electro-dialysis reaching D50-70 whey grade or combined with Applexion ion exchange to reach D90 whey grade.
• Lactose purification with Applexion ion exchange and nano-filtration
• Production of crystalline lactose using Applexion SSMB chromatography

Novasep will continue to sell biopharma chromatography equipment and associated processes in India.

“India is one of the most dynamic areas where Novasep’s expertise can meet manufacturer expectations for state-of-the-art processes,” said Nadège Laborde, President of the Industrial Biotech Business Unit. “Novasep has a complete portfolio of technologies and extensive know-how in industrial purification technologies for the food and feed ingredient industries. Michel Cotillon’s strong technical expertise and leadership as General Manager of Novasep Process Engineering Services will ensure our successful development in India.”

Novasep India will continue to collaborate with the Nilsan Nishotech Systems Pvt. Ltd. team, which has represented Novasep in India for more than 20 years.

Nilsan Nishotech will remain the exclusive agent for Novasep for industrial biotech and biopharma purification processes and systems in India.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Novasep, Triclinic Labs Partner
Partnership will enable Novasep to offer early-stage solid-state chemistry services in North America.
Thursday, September 15, 2016
Novasep Adds Synthesis and Kilo Lab Extensions to US Facility
Enhanced capabilities bring Novasep’s unique range of specialized drug development technologies within easier reach of North American customers.
Saturday, February 06, 2016
Novasep, Advanced Biotherapeutics Team Up
Strategic partnership creates a world leading CDMO offer to supply AAV-based viral vectors, an increasingly attractive therapeutic platform for gene therapy.
Wednesday, January 13, 2016
Novasep Further Strengthens Management Team
Pierre-Louis Mikus joins as chief legal officer and Bertrand Waymel is promoted to group human resources director.
Wednesday, May 06, 2015
Novasep Enters into an Agreement with Celladon
Company selected to commercially biomanufacture Celladon's Mydicar API.
Thursday, February 19, 2015
Novasep Opens New Office in Thailand
Novasep’s extended presence in South East Asia strengthens the company’s ability to address growing needs in the region’s food and feed markets.
Saturday, December 27, 2014
Novasep to Sell its Bahamian Plant to Local Investor
Company has completed the sale of the Bahamian facility and related business of its fully-owned subsidiary, Pharmachem.
Thursday, October 09, 2014
Novasep Passes FDA Inspections on Two Sites
Novasep wins approval to produce new molecular entity for US market.
Thursday, July 24, 2014
Novasep’s €4 M ADC Manufacturing Plant Extension Commissioned
The new Highly Potent API manufacturing capacity at the Le Mans facility will boost Novasep’s ability to meet customer demand for producing anti-cancer therapies.
Friday, May 16, 2014
Novasep Attracts Top Talent to Complete its Executive Team
Thierry Van Nieuwenhove, a seasoned CMO top executive, joins Novasep as president of the Synthesis Business Unit.
Monday, January 20, 2014
Novasep Appoints Nadege Laborde as President of its Industrial Biotech Business Unit
This internal promotion strengthens the business unit and enhances the Executive Committee (COMEX).
Friday, November 22, 2013
Novasep’s European Custom Manufacturing Passes FDA Inspection
Two successful FDA inspections assure customers of Novasep’s strict compliance with US pharmaceutical processing standards.
Thursday, October 24, 2013
Novasep Appoints Christian Thiry as Chief Financial Officer
CFO appointment is a key milestone in Novasep’s senior management recruitment program.
Thursday, August 29, 2013
Michel Spagnol Appointed President and CEO of Novasep
Appointment of Michel Spagnol effective from June 25, 2013.
Thursday, June 27, 2013
Novasep Opens New Shanghai Facilities
New site increases Novasep’s process development and engineering capabilities to supply turnkey purification processes in East Asia.
Thursday, March 29, 2012
Scientific News
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!